Judith V. Hobrath

High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv

Subramaniam Ananthan, Ellen R. Faaleolea, Robert C. Goldman et al. · Tuberculosis · 2009 · 277 citations

Pulmonary Tuberculosis, Health Sciences, Tuberculosis Prevention +10

Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition

Susan Wyllie, Stephen Brand, Michael G. Thomas et al. · Proceedings of the National Academy of Sciences · 2019 · 165 citations · Full text

Antituberculosis activity of the molecular libraries screening center network library

Joseph A. Maddry, Subramaniam Ananthan, Robert C. Goldman et al. · Tuberculosis · 2009 · 151 citations · Full text

Targeted Library, Medicinal Chemistry, Pulmonary Tuberculosis +12

A Novel Sulindac Derivative That Does Not Inhibit Cyclooxygenases but Potently Inhibits Colon Tumor Cell Growth and Induces Apoptosis with Antitumor Activity

Gary A. Piazza, Adam B. Keeton, Heather N. Tinsley et al. · Cancer Prevention Research · 2009 · 97 citations · Full text

High throughput screening of a library based on kinase inhibitor scaffolds against Mycobacterium tuberculosis H37Rv

Robert C. Reynolds, Subramaniam Ananthan, Ellen R. Faaleolea et al. · Tuberculosis · 2011 · 96 citations · Full text

Targeted Library, Pulmonary Tuberculosis, High Throughput Screening +11